News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Novartis AG, Roche’s Xolair Helps Kids With Severe Milk Allergies
March 22, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
March 21 (Bloomberg) -- Novartis AG and Roche Holding AG’s Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study showed.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Novartis
MORE ON THIS TOPIC
CAR-T
Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events
September 1, 2026
·
3 min read
·
Tristan Manalac
Cardiovascular disease
Arrowhead’s new Redemplo findings in severe hypertriglyceridemia have analysts split
August 31, 2026
·
3 min read
·
Tristan Manalac
Cancer
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
August 28, 2026
·
2 min read
·
Heather McKenzie
cardiovascular disease
‘Worse than expected’ Wainua data muddies water for TTR silencers
August 28, 2026
·
2 min read
·
Gabrielle Masson